The second revision of the International Staging System (R2-ISS) stratifies progression-free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population

Br J Haematol. 2023 Jan;200(2):e17-e21. doi: 10.1111/bjh.18536. Epub 2022 Nov 2.
No abstract available

Keywords: cancer cytogenetics; myeloma; prognostic factors.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Australia / epidemiology
  • Disease-Free Survival
  • Humans
  • Multiple Myeloma*
  • Neoplasm Staging
  • New Zealand / epidemiology
  • Prognosis
  • Retrospective Studies